Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. - Wikidata - awgldk - TriplyDB

Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment.

Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment.

http://www.wikidata.org/entity/Q34128192

about

Drug interventions for the treatment of obesity in children and adolescents Vancomycin-Associated Nephrotoxicity: The Obesity Factor Investigation of Vitamin D-Binding Protein Polymorphism Impact on Coronary Artery Disease and Relationship with Longevity: Own Data and a Review Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: a study protocol for a randomized controlled cli Importance of android/gynoid fat ratio in predicting metabolic and cardiovascular disease risk in normal weight as well as overweight and obese children Periodontal status among patients with diabetes in Nuuk, Greenland.The impact of abdominal adiposity measured by sonography on the pulmonary function of pre-menopausal females.Cardiovascular risk factor investigation: a pediatric issue.Level of information about the relationship between diabetes mellitus and periodontitis--results from a nationwide diabetes information program Effect of a High Protein Weight Loss Diet on Weight, High-Sensitivity C-Reactive Protein, and Cardiovascular Risk among Overweight and Obese Women: A Parallel Clinical Trial.A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients How young people cope with chronic kidney disease: literature review.Obese Adolescents Show Reduced Cognitive Processing Speed Compared with Healthy Weight Peers.Metabolic syndrome in children and adolescents: Old concepts in a young population.Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women.The Banishing Obesity and Diabetes in Youth (BODY) Project: description and feasibility of a program to halt obesity-associated disease among urban high school students.Frequency of obesity and related risk factors among school children and adolescents in a low-income community. A cross-sectional study.Association between insulin-like growth factor-1, measures of overnutrition and undernutrition and insulin resistance in black adolescents living in the North-West Province, South Africa.Independent association of clustered metabolic risk factors with cardiorespiratory fitness in youth aged 11-17 years.Maternal obesity, diabetes during pregnancy and epigenetic mechanisms that influence the developmental origins of cardiometabolic disease in the offspring.Molecular features related to the binding mode of PPARδ agonists from QSAR and docking analyses.The effectiveness of a physical activity and nutrition education program in the prevention of overweight in schoolchildren in Criciúma, Brazil.Physical Exercise Prescription in Metabolic Chronic Disease.Outcomes of The BODY Project: A Program to Halt Obesity and Its Medical Consequences in High School Students.Prevalence of dyslipidaemia and associated risk factors among Balearic Islands adolescents, a Mediterranean region.Dietary factors associated with subclinical inflammation among girls.Effects of recommendations to follow the Dietary Approaches to Stop Hypertension (DASH) diet v. usual dietary advice on childhood metabolic syndrome: a randomised cross-over clinical trial.Association of dietary patterns with continuous metabolic syndrome in children and adolescents; a nationwide propensity score-matched analysis: the CASPIAN-V study.New Insights about How to Make an Intervention in Children and Adolescents with Metabolic Syndrome: Diet, Exercise vs. Changes in Body Composition. A Systematic Review of RCT

P2860

Q28279770-3047F2E9-EA7D-4A14-8CE6-0FF7B29399A3 Q30278775-3EB9AACD-AB2A-42E0-B35E-94C46134C1CF Q31090216-91311AC1-8911-4E0C-9D3C-952895293CC4 Q33940070-30EC8184-B3C0-4A74-B8E3-87EA707478A9 Q34273546-106B5F47-AEF6-484E-9927-1CCF0C3B75AE Q34692355-D447C4C0-C75F-4B3B-8115-1D80CE27D33B Q35899317-ED20137D-9E06-465F-AD43-938CE45DEAE3 Q36687298-B4835172-C3A9-4983-97DE-0CB219F7C8F4 Q36707713-AD3D5F6D-A1A9-406A-87B2-73E1812FB08B Q37108761-A05973F4-1CF8-4D4A-8731-CB3107E82D3D Q37132420-92EBF62C-FA75-46ED-8962-E4E7804FAD90 Q38062016-38A2456A-8466-4CAB-9AA8-D1BE8AA363DC Q38751124-0C17E494-EBE9-4165-9B11-4D1EDF737C5A Q38853283-7E51EC33-45D4-40A0-BB6A-C24F672EEDDF Q39017494-8E88F93C-BF64-48BC-A7AD-260213D7823C Q39994036-61957487-B0A8-4C64-BBE5-64FC73C8F174 Q40895608-ADF0A8D7-E04B-4BD5-B192-02E78A0FE6EC Q43689073-3BAB4815-EC92-446B-AE06-9D0F43F15B97 Q47656256-7EA1D4B3-7A0B-4AE7-8332-89E17760C6FC Q47747116-F03044E2-5176-4368-8E28-CE79E0A2CD8B Q48324878-128DC086-1072-450E-9DF2-FA69026FA547 Q48337293-E019E4DD-D6D7-494B-8819-5B994D8866A8 Q48659198-06DA18FA-43F5-41DB-9CE5-367B003EC7E9 Q50551941-1D97DB04-03BF-41CF-A286-E746840D1CEA Q51313560-3453862D-594F-4CF7-9953-C21929EA0875 Q51332403-59DACAD3-AF1C-449A-9DCE-E8F22DB911E2 Q51338957-B1FE27CD-6D2F-4747-B05A-738F8682C46F Q55517937-FBB74906-CAD5-4E10-8CD3-8B7F295DB08D Q57176979-8AE2FB62-CF26-45A1-91AA-791E2F3C43A0

P2860

Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment.

http://www.wikidata.org/entity/Q34128192

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Metabolic syndrome, dyslipidem ...... : from diagnosis to treatment.

@ast

Metabolic syndrome, dyslipidem ...... : from diagnosis to treatment.

@en

Metabolic syndrome, dyslipidem ...... : from diagnosis to treatment.

@nl

type

label

Metabolic syndrome, dyslipidem ...... : from diagnosis to treatment.

@ast

Metabolic syndrome, dyslipidem ...... : from diagnosis to treatment.

@en

Metabolic syndrome, dyslipidem ...... : from diagnosis to treatment.

@nl

prefLabel

Metabolic syndrome, dyslipidem ...... : from diagnosis to treatment.

@ast

Metabolic syndrome, dyslipidem ...... : from diagnosis to treatment.

@en

Metabolic syndrome, dyslipidem ...... : from diagnosis to treatment.

@nl

P1433

Q34128192-6E2D6427-BF49-484E-BBED-585575B95A6C

P1476

Q34128192-48F9F460-7541-4DFE-BD61-BE8F69FFB3F4

P2093

Q34128192-0733CC87-C1FD-4967-9620-B088600DE87A

Q34128192-11D07976-48CA-4D9E-B0F2-9BA3FA6430B5

Q34128192-1818C4EA-F28F-4830-96F9-4D1B2A43F50C

Q34128192-400DC623-B089-43B1-94F7-72626C8CF387

Q34128192-480AE4D9-41A4-4770-A250-DF3AF3489E5A

Q34128192-49F82792-61AD-448A-B523-5E1A813208A4

Q34128192-8604042D-D874-467F-99A9-B83D290B3638

Q34128192-CD7FA68D-96AC-47BC-85D5-2E3BFFBFE289

Q34128192-DBC9F121-0BEA-4DDE-AA38-C9477E9F415F

Q34128192-EAAD255A-A009-4F03-961E-1FA1F085FDA2

P2860

Q34128192-0106F551-461A-423B-BBCC-40105FA74236

Q34128192-041F77DF-5E3C-4F85-A32D-5DB0C89DCB54

Q34128192-14344F07-DEC3-4E5E-893F-F83A882B6F3F

Q34128192-157982F0-74BB-4845-A524-B16F7609EA63

Q34128192-1A97E8F5-5B33-4B2C-AE82-A92DE2BE60F1

Q34128192-1CE24EFE-5B00-4336-A472-63AAB89CC0AE

Q34128192-1E763951-5825-4047-BCBC-27F2DEE9A9B0

Q34128192-228B79FA-D1C3-46C4-B250-0E8EF63596BB

Q34128192-2423914D-E358-4A92-9D0F-5C92D1CFF7CD

Q34128192-26A87380-3B26-44AD-A6FE-E66F3174A5A2

P2888

Q34128192-634DE3B0-A1ED-4FE1-AE65-ED4B277FB697

P304

Q34128192-7E522AEB-C4F8-4985-BD16-F9AC2DF1C0A8

P31

Q34128192-EB9C025A-9349-4B6D-A46C-64CE5BC40E81

P356

Q34128192-9C61EB64-E706-44DA-A67D-70EB2A792529

P478

Q34128192-E27DBBC3-3177-4482-9261-C2150F9A87A9

P577

Q34128192-7426CE25-9019-47D9-96B9-9F9F4BE65CDE

P5875

Q34128192-B12B678B-D8BE-458F-8593-5F2124C4DA07

P6179

Q34128192-3D99D2A9-D1A2-4141-BDE0-DA0A5C295E99

P698

Q34128192-5F59DF80-6ACC-48B5-8B6F-7F3AF90F1F83

P921

Q34128192-7C75D77D-8319-44B0-9736-826F9F3B1BEE

Q34128192-C1E58503-B598-44FC-95DB-C5FAA7278E70

Q34128192-DCB82C7E-9ADA-4DC1-A686-F13DC60DFC69

P932

Q34128192-198CD2B5-CF44-404C-83BC-9D1182977E70

P356

P1433

Diabetology and Metabolic Syndrome

P1476

Metabolic syndrome, dyslipidem ...... : from diagnosis to treatment.

@en

P2093

Adriana Bertolami

http://www.w3.org/2001/XMLSchema#string

Alfredo Halpern

http://www.w3.org/2001/XMLSchema#string

Marcelo C Bertolami

http://www.w3.org/2001/XMLSchema#string

Marcia Nery

http://www.w3.org/2001/XMLSchema#string

Marcia S Queiroz

http://www.w3.org/2001/XMLSchema#string

Marcio C Mancini

http://www.w3.org/2001/XMLSchema#string

Maria Edna de Melo

http://www.w3.org/2001/XMLSchema#string

Maria Eliane C Magalhães

http://www.w3.org/2001/XMLSchema#string

Maria Teresa Zanella

http://www.w3.org/2001/XMLSchema#string

Mauro Fisberg

http://www.w3.org/2001/XMLSchema#string

P2860

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

Pediatric hyperglycemic hyperosmolar syndrome: diagnostic difficulties and high mortality rate.

Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia.

Type II diabetes mellitus: no longer just adults.

Nutrition transition and its relationship to the development of obesity and related chronic diseases.

Developmental changes in energy expenditure and physical activity in children: evidence for a decline in physical activity in girls before puberty.

Early intensive insulin treatment for induction of long-term glycaemic control in type 2 diabetes.

The kidney, hypertension, and obesity.

P2888

P304

55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1758-5996-2-55

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45706949

http://www.w3.org/2001/XMLSchema#string

P6179

1040047809

http://www.w3.org/2001/XMLSchema#string

P698

20718958

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

metabolic syndrome

P932

2939537

http://www.w3.org/2001/XMLSchema#string